Patent details

LUC00108 Product Name: Durvalumab

Basic Information

Publication number:
LUC00108
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP009593948
Legal Status:
Expired
Application number:
LUC00108
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1322
Marketing Authorization Type:
Marketing Authorization Date:
25/09/2018
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
13/03/2019
First Marketing Authorization date:
25/09/2018
Grant date:
20/11/2019
Activation date:
23/08/2020
Publication date:
18/03/2019
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
23/08/2025
SPC Extension Expiration:
23/08/2025
Rejection date:
Withdrawal date:

Owner

From:
13/03/2019
 
 

Name:
Dana-Farber Cancer Institute Inc.
Address:
450 Brookline Avenue, Boston, MA 02215, United States (US)

Name:
Genetics Institute LLC
Address:
87 Cambridge Park Drive, Cambridge, MA 02140, United States (US)

Agent

Name:
ARONOVA S.A.
From:
13/03/2019
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2019/05
Publication date:
11/04/2019
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2019/13
Publication date:
20/12/2019
Description:
Section D : Granted supplementary protection certificates – I2 publication

3

Bulletin Heading:
SPC3
Bulletin edition number:
2020/10
Publication date:
04/09/2020
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
30/07/2024
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages
13/03/2019 Application Form 4
13/03/2019 General Document 36
18/03/2019 Publication 1
13/03/2019 General Document 4
20/11/2019 Outgoing Correspondence 1
13/03/2019 General Document 3
13/03/2019 Incoming Correspondence (Post) 1
20/11/2019 Publication 1
18/03/2019 Outgoing Correspondence 1
20/11/2019 Certificate 1
08/11/2019 Incoming Correspondence (Post) 1